TickerFacts.

Bio Essence Corp (BIOE): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$2.07M
As of 2025-12-31
$2.34M
As of 2026-06-30
2020-12-31: -$1.78M2021-12-31: -$2.43M2022-12-31: -$3.24M2023-12-31: -$1.66M2024-12-31: -$2.97M2025-12-31: -$2.07M-$2.07M
2020-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$2.07Mn/m2026-03-27, Balance as of period end
2024-12-31-$2.97Mn/m2026-03-27, Balance as of period end
2023-12-31-$1.66Mn/m2025-03-28, Balance as of period end
2022-12-31-$3.24Mn/m2024-04-15, Balance as of period end
2021-12-31-$2.43Mn/m2023-03-30, Balance as of period end
2020-12-31-$1.78Mn/a2022-03-31, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Bio Essence Corp (BIOE)2025-12-31-$2.07Mn/m
Lipocine Inc. (LPCN)2025-12-31$14.48M-31.1%
Dianthus Therapeutics, Inc. (DNTH)2025-12-31$493.40M+40.0%
Korsana Biosciences, Inc. (KRSA)2025-12-31$9.09M+2.7%
Rani Therapeutics Holdings, Inc. (RANI)2025-12-31$33.01Mn/m
GeoVax Labs, Inc. (GOVX)2025-12-31$3.83M-24.2%
NRX Pharmaceuticals, Inc. (NRXP)2025-12-31-$15.94Mn/m
Avenue Therapeutics, Inc. (ATXI)2025-12-31$1.83M-34.5%
Northwest Biotherapeutics Inc (NWBO)2025-12-31-$60.28Mn/m

Compare BIOE, LPCN, DNTH, KRSA side by side · Screen every company in Pharmaceutical Preparations ↗